My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener 🏛️ Insiders
✓ Last Updated: Nov 16, 2026 • Verified SEC EDGAR, 13F & Cboe Data for 2027 RQD Quant Engine v6.2 Live

UnitedHealth Group Incorporated (UNH) — RQD Stock Rating Cockpit

$330.37 -5.58% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $326.42

UnitedHealth Group Incorporated (UNH) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $296.02B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UNH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UNH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-22, UnitedHealth Group Incorporated (NYSE: UNH) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $330.37 (-5.58% 1D, market cap $296.02B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 13/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 13/20. Active quantitative signal GOVT_CONTRACT (BULLISH, conviction undefined/100) notes: undefined.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UNH compare to PM and NVS in the Health Care sector?
▼

Within the Health Care sector (Managed Health Care, Medicare Advantage & Optum Services), UNH carries a Roarable C+ (68/100 RQD), trailing P/E of 19.0x, gross margin of 88.3%, and ROIC of 12.4%. By comparison, PM (Philip Morris International Inc) holds a B grade (72/100 RQD, P/E 28.6x, ROIC 45.3%, cap $290.58B) and NVS (Novartis AG) posts a D+ grade (56/100 RQD, P/E 32.8x, ROIC 9.9%, cap $288.61B). Among the 5-stock peer group, UNH leads on earnings multiple (19.0x) while PM leads on capital efficiency (45.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UNH?
▼

Per UNH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-02, CIK 0000731766), UnitedHealth Group Incorporated generated $447.57B in revenue (+11.8% YoY), $12.06B in net income, and $16.07B in free cash flow against $309.58B in total assets and $77.68B in total debt. Key quantitative strengths: Backed by newly obligated U.S. federal government contract revenue. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Latest SEC insider/13F disclosure shows Sen. Tina Smith (Politician) executed a BUY of 2,470 shares ($1.0M) on 2026-11-16.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 UNH TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY • HARD STOP-LOSS (SUP) • TARGET (RES) • WHY

Where to Enter $UNH, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

🏆 RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP • $UNH R/R 2.9 : 1 • RQD 68/100 (C+)
$UNH
Spot $330.37
1. GET IN (ENTRY)
$328.39–$332.02
2. HARD STOP (SUP)
$315.50 (-4.5%)
3. GET OUT (T1/T2)
$356.14 / $373.98
STOP-LOSS FLOOR (SUP $315.50): Hard stop sits 4.5% below spot to cap downside below key institutional support. If $UNH closes a daily candle below $315.50, step aside.
PROFIT TARGETS (RES $356.14 / $373.98): Scale out 50% at T1 (+7.8%) and trail stop to breakeven for T2 (+13.2%).
Want this $UNH sheet + Today's Top 3 Trades emailed free? Paper Trade $UNH →
⚡ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked • Enter Email Below to Unblur #2 & #3 + Get $UNH Sheet
#1 • $ANET R/R 2.6 : 1
Arista Networks Inc.
IN
$164.14
STOP
$154.80
OUT
$178.00
#2 • 🔒 LOCKED R/R 2.6 : 1
AI Liquid-Cooling Leader
Target: +8.81% to +15.06% | Stop: -5.73%
#3 • 🔒 LOCKED R/R 2.3 : 1
Cash-Flow Buyback Machine
Target: +6.22% to +10.48% | Stop: -4.52%
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $326.44 (-1.19%)🧬 Cannibal Buyback (-1.94% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 3.6% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 68/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.8% avg 90D alpha vs SPY • 56.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510068
2-of-3 Quant Analysts Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw C+ · Rk B-
Cash (14)Whales (13)SEC (16)Macro (12)CEO (13)
Each axis scored 0–20
12M PRICE TARGET CONE+24.2% Base Target
$445 Bull$410 Base$361 Bear
📬 FREE UNH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS POSITIONING:54% Calls (P/C 0.85x)
46% PutsMax Pain: $339.85
Deterministic 5-Pillar Attribution (68/100 Composite)
🔍 WHY UNH SCORES 68/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (24% of score)

Altman Z-Score 2.91 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 3.6% FCF Margin ($16.07B FCF) & 88.7% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit12/20 pts (-8 pt drag)

Macro rate sensitivity & RSI-14 (36.4) create a -8 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
76
Grade B+$401.73-6.2% Next Q
Q2 (-2Q)
73
Grade B$376.90+10.9% Next Q
Q3 (-1Q)
71
Grade B$418.09-21% Next Q
Current
68
Grade C+$330.37+1.8% Hist 90D α
Trajectory: B+ (76) → C+ (68)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UNH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

UnitedHealth Group's FY2025 Form 10-K (accession 0000731766-26-000062) signals operational friction and top-line slowdown across its high-margin analytics franchise, evidenced by a $1.7B contraction in total Optum Insight backlog and an explicit $1.5B drop in 12-month expected realization. Concurrently, management discloses an unheralded 2026 business realignment alongside condensed risk-transfer disclosures in commercial benefits, indicating internal restructuring pressures to defend margins against elevated medical loss ratios and heightened regulatory scrutiny across Medicare Advantage and payment integrity operations.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.94% YoY Shares) — any gross margin slip below 86.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($361.24) or 200D SMA ($445.13) invalidates the momentum regime and cuts Target Base ($410.24) toward Bear Floor ($361.24).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UNH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “UNH Beats Next Quarter EPS Consensus (Feb 2, 2027) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
36.430 Oversold · 70 Hot
ALTMAN-Z SHIELDWATCH ZONE (1.8–3.0)
2.91>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE24% OF RANGE
L: $235$330.37H: $631
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (88.3% gross margin), though cash flow growth is moderate rather than explosive right now.

Factor Grade: B-RQD 14 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

2-of-3 Quant Analysts Bullish on UNH

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (70)

12.4% ROIC with 88.3% gross margin and 7.55% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (80)

Altman-Z 2.91 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
NEUTRAL (63)

Put/Call 0.85x with 26/40 institutional & insider flow.

Bull Case: Why Buyers Like UNH
  • ✓Backed by newly obligated U.S. federal government contract revenue.
  • ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
Bear Case: What Could Go Wrong
  • !Broader market pullbacks can still drag down strong stocks in the short run.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in UNH & A-Rated Leaders

  • ✓12-month Bull/Base/Bear fair-value walkthrough on UNH and its top sector peer
  • ✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
  • ✓Includes nightly RQD rating-change & forensic signal email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
UNH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -13.13%▼ SUPPORT BREAKDOWN
2026-11-22O $349.9H $349.9L $330.4C $330.4VOL 19.84M
$471.2$431.5$391.8$352.1$312.3RES $443.2SUP $334.3$330.42026-05-292026-07-102026-08-282026-10-092026-11-22
🏛️ GURU-GRADE VALUATION & FORENSIC ACCOUNTING ENGINE NARROW ECONOMIC MOAT (ROIC 12.4% vs WACC 6.2%)

UNH Intrinsic Fair Value Line, Peter Lynch Corridor, Forensic Trio & Warning Signs

1-SECOND VISUAL VALUATION ANCHOR (COMPOSITE DCF + PETER LYNCH + GRAHAM)
Fair Value: $413.08 vs Spot $330.37
SIGNIFICANTLY UNDERVALUED (+20.0%)
Undervalued Zone (< $351) Fair Value Corridor ($351–$475) Overvalued (> $475)
$330
⚡ INTERACTIVE 10-YEAR DCF SANDBOX

Test Your Own UNH Growth & WACC Assumptions

YOUR DCF TARGET
$611.18
5-Yr Annual FCF Growth Rate: 10.0%
Discount Rate (WACC Hurdle): 6.2%
Year-10 Terminal FCF Multiple: 16.0x
Margin of Safety: +20.0% vs $330.37 Full DCF Table →
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UNH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor
-1.94% YoY Shares

SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.

Reverse-DCF Expectations Hurdle
12.4%/yr Implied 5Y Growth

vs. +11.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on UNH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →
LLY → UNH Confirmed Filing
FDA label expansions of GLP-1 drugs into cardiovascular risk reduction, obstructive sleep apnea, and kidney disease unlock Medicare Part D statutory coverage, elevating UnitedHealthcare specialty drug costs.
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UNH)

Health Care Rank #67 of 1015 ⚔️ PM vs UNH Full Matrix →

1. Head-to-Head Health Care Peer Comparison (UNH vs. PM, NVS, AZN, MRK)

Industry: Managed Health Care, Medicare Advantage & Optum Services (1 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, UnitedHealth Group Incorporated (UNH) ranks #67 by composite RQD confidence (68/100, grade C+) and #5 by equity capitalization ($296.02B). Within this direct 5-issuer industry benchmark cohort, UNH leads on earnings valuation at 19.0x trailing P/E, while PM leads on capital efficiency and profitability with 45.3% ROIC and 67.1% gross margin. PM currently holds the highest overall quantitative score in the immediate peer group at 72/100 (B) compared with UNH at 68/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
UNH ACTIVE
UnitedHealth Group Incorporated
C+ 68/100 19.0x 88.3% 12.4% -5.58% $296.02B Benchmark Subject
PM
Philip Morris International Inc
B 72/100 28.6x 67.1% 45.3% -3.27% $290.58B /pm-vs-unh →
NVS
Novartis AG
D+ 56/100 32.8x — 9.9% -2.55% $288.61B /nvs-vs-unh →
AZN
AstraZeneca PLC
D+ 56/100 32.8x — 9.9% -1.91% $271.90B /azn-vs-unh →
MRK
Merck & Company Inc.
C+ 69/100 19.8x 74.8% 20.7% -3.66% $327.24B /mrk-vs-unh →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2021–FY2025)

SEC EDGAR 10-K • FILED 2026-03-02 • CIK 0000731766 ↗

In its most recent audited fiscal period (FY2025, filed 2026-03-02), UnitedHealth Group Incorporated (UNH) reported GAAP revenue of $447.57B (+11.8% vs. FY2024 revenue of $400.28B , and +55.6% cumulative change since FY2021) , GAAP net income of $12.06B, operating cash flow of $19.70B, and free cash flow of $16.07B (-22.4% YoY). On the balance sheet, UNH closed FY2025 with $309.58B in total assets against $77.68B in total debt (Altman Z-Score: 2.91, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-02 $447.57B $12.06B $19.70B $16.07B $309.58B $77.68B
FY2024 (FY) 2026-03-02 $400.28B $14.40B $24.20B $20.70B $298.28B $76.18B
FY2023 (FY) 2026-03-02 $371.62B $22.38B $29.07B $25.68B $273.72B $61.47B
FY2022 (FY) 2025-02-27 $324.16B $20.12B $26.21B $23.40B $245.71B $56.76B
FY2021 (FY) 2024-02-28 $287.60B $17.29B $22.34B $19.89B $212.21B $44.63B

3. UNH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UNH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-22, UnitedHealth Group Incorporated (NYSE: UNH) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $330.37 (-5.58% 1D, market cap $296.02B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 13/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 13/20. Active quantitative signal GOVT_CONTRACT (BULLISH, conviction undefined/100) notes: undefined.

How does UNH compare to PM and NVS in the Health Care sector?

Within the Health Care sector (Managed Health Care, Medicare Advantage & Optum Services), UNH carries a Roarable C+ (68/100 RQD), trailing P/E of 19.0x, gross margin of 88.3%, and ROIC of 12.4%. By comparison, PM (Philip Morris International Inc) holds a B grade (72/100 RQD, P/E 28.6x, ROIC 45.3%, cap $290.58B) and NVS (Novartis AG) posts a D+ grade (56/100 RQD, P/E 32.8x, ROIC 9.9%, cap $288.61B). Among the 5-stock peer group, UNH leads on earnings multiple (19.0x) while PM leads on capital efficiency (45.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for UNH?

Per UNH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-02, CIK 0000731766), UnitedHealth Group Incorporated generated $447.57B in revenue (+11.8% YoY), $12.06B in net income, and $16.07B in free cash flow against $309.58B in total assets and $77.68B in total debt. Key quantitative strengths: Backed by newly obligated U.S. federal government contract revenue. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Latest SEC insider/13F disclosure shows Sen. Tina Smith (Politician) executed a BUY of 2,470 shares ($1.0M) on 2026-11-16.

Where is UNH trading relative to its 50-day, 200-day, and 52-week technical levels?

UNH last traded at $330.37 (-5.58% on volume of 19,837,191 shares), positioning the stock -8.55% below its 50-day simple moving average ($361.24) and -25.78% below its 200-day simple moving average ($445.13). Across its 52-week range of $234.60 to $630.73, UNH sits at the 24.2% percentile with a 14-day RSI of 36.4 (NEUTRAL RANGE) and an implied next-earnings move of ±5.5% ($312.20 to $348.54).

ROARABLE RATING BRIEF • RQD 68/100 (C+) ✓ SEC XBRL & RQD VERIFIED

UNH — UnitedHealth Group Incorporated: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-02

1. Roarable Rating Brief: What This Means to a Prospective Investor

UnitedHealth Group Incorporated (UNH) earns a live Roarable RQD composite score of 68/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $330.37 (-5.58% 1D, market capitalization $296.02B).

  • Fundamental Cash Engine (14/20): Anchored by return on invested capital (ROIC) of 12.4%, gross margin of 88.3%, operating margin of 5.3%, and free cash flow yield of 7.55%.
  • Whale 13F & Options Flow (13/20) + Insider Conviction (13/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (12/20) + Forensic Balance Sheet (16/20): Incorporates a 0.34x equity beta, Altman Z-Score of 2.91, Piotroski F-Score of 7/9, and Debt/Equity of 0.71x.

2. Business Model, Unit Margins & SEC Financial Trajectory

.S. Healthcare enterprise, operating in the Health Care sector and the Managed Health Care, Medicare Advantage & Optum Services industry on the NYSE. Its UnitedHealthcare segment provides insurance benefits across commercial, Medicare Advantage, and Medicaid populations. Optum Health delivers value-based physician care, OptumRx operates pharmacy benefit management, and Optum Insight provides health IT analytics. The largest customer exposures are CMS (Medicare Advantage and state Medicaid agencies) at 44% of revenue and self-insured employers and commercial sponsors at 38%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-02), UnitedHealth Group Incorporated (UNH) reported $447.57B in annual revenue (up from $400.28B in FY2024, +11.8% YoY) and $12.06B in GAAP net income. Over the multi-year SEC filing window from FY2021 ($287.60B revenue, $17.29B net income) through FY2025, UNH scaled operating cash flow to $19.70B and free cash flow to $16.07B, backed by $309.58B in total assets against $77.68B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C+ • RQD 68/100): Backed by newly obligated U.S. Federal government contract revenue. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 14/20 and Institutional Whale Flow at 13/20, sustained execution supports upside toward the upper end of the $234.60 – $630.73 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 19.0x trailing P/E and 12.9x EV/EBITDA against 5.3% operating margins and a 0.34x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

UNH's suppliers include Eli Lilly, Novo Nordisk, and branded biopharma manufacturers at 28% revenue exposure (GLP-1 and specialty biologics negotiated via OptumRx), and HCA Healthcare and acute-care hospital systems at 45% exposure (approximately 85% of the medical care ratio cost pool). Both are classified as CRITICAL. The primary 2nd-order risk identified in the graph is the GLP-1 link: label expansions into cardiovascular risk reduction, sleep apnea, and kidney disease could expand Part D specialty drug utilization faster than Medicare Advantage benchmark rates adjust, pressuring the medical care ratio until premiums reprice. The graph notes a competing explanation: OptumRx rebate retention and prior-authorization controls may partially offset gross GLP-1 spend. Competitors listed include CVS Health (85% revenue exposure, CRITICAL), Elevance Health and The Cigna Group (78%, CRITICAL), and Humana (36%, HIGH), indicating overlapping Medicare and commercial markets where pricing and reimbursement dynamics are shared. Investors should watch the CMS Part D guidance and the next medical care ratio print as the two identified near-term checkpoints.

  • Key Question #1: Can UNH sustain or expand its 5.3% operating margin and 12.4% ROIC against Managed Health Care, Medicare Advantage & Optum Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $447.57B and free cash flow of $16.07B, how will capital allocation balance growth reinvestment against $77.68B in total debt?
  • Key Question #3: How sensitive is UNH's 17.7x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.34x)?

UNH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for UnitedHealth Group Incorporated (UNH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to UNH Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

UNH Bull vs. Bear Conversation Board — What's Your Call at $330.37?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON UNH 🐻 33% BEARISH CONVICTION
1. Pick Your Side on UNH:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $480.22 (+18.0%)
📌 Pinned Debate

Analysts' consensus of 19 Buy and 0 Sell ratings, with a target mean of $491.26 implying 20.71% upside, alongside a forward P/E of 17.7

Here is why I am bullish on UNH here at $406.97: Analysts' consensus of 19 Buy and 0 Sell ratings, with a target mean of $491.26 implying 20.71% upside, alongside a forward P/E of 17.7 and a 2.28% dividend yield.. Compare UNH's 4.8% operating margin and 11.5% ROIC against the rest of Managed Health Care, Medicare Advantage & Optum Services. As long as cash conversion holds up, dips toward $386.62 are getting bought.

CapAlloc_Nerd 🐂 BULL

@DeltaGamma_99 Agree on the RQD 68/100 quality, though with 0.33 beta I'm scaling in with half-size at $406.97 and keeping dry powder in case we test $378.48.

MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH 🎯 Target: $305.23 (-25.0%)
Spot @ $406.97

Valuation & margin reality check on UNH at $406.97 before chasing here

Careful chasing UNH at $406.97. Valuation & margin reality check on UNH at $406.97 before chasing here. Gross margin is 88.6%, but operating margin is 4.8%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $305.23 on multiple compression.

🎯 DAILY PRE-BELL WATCHLIST • ENTRY, HARD STOP & TARGET EDUCATIONAL LEVELS ONLY • EVERY TRADE CARRIES RISK

3 Stocks on Our Radar Today — Entry, Hard Stop & Why

📊 Recent Paper Examples (Not Typical Real-Money Results): $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
TRADE #1 OF THE DAY R/R 2.6 : 1 • RQD 88 (A+)
$ANET Arista Networks Inc.
LONG (BUY SETUP)
1. Get In (Entry)
$164.14
2. Hard Stop
$154.80 (-5.7%)
3. Get Out (T1/T2)
$178.00 / $188.50
Entry Rule: Buy between $162.50 – $165.00 (or on 15-min candle reclaim above $165.40)
Stop Logic: Hard stop at $154.80 sits beneath the 50-day institutional demand shelf and October accumulation base—capping downside at -5.69% while targeting $178.00 to $188.50 (+14.84%).
4. Why Now: Microsoft (+6.68%) and Amazon (+6.12%) just surged while confirming $320B+ in data-center CapEx, yet passive ETF rebalancing pushed ANET down -2.79% to $164.14. Arista owns the 64.1% gross-margin 800G/1.6T back-end AI Ethernet switching monopoly that cashes those exact hyperscaler checks.
Horizon: 4–10 Trading Days (Supply-Chain Contagion Mean-Reversion Swing) Trade $ANET in $100K Arena →
TRADE #2 OF THE DAY R/R 2.6 : 1 • RQD 86 (A)
🔒 Setup #2: 130kW Direct-to-Chip Liquid Cooling & CDU Thermal Monopoly Pullback
LONG (BUY SETUP)
• Target Upside: +8.8% (T1) to +15.1% (T2)
• Max Downside Stop: -5.7% Hard Floor (2.6 : 1 R/R)
Order book sold out through 2027 on key VWAP support. Enter your email below for the ticker, buy trigger, and stop.
TRADE #3 OF THE DAY R/R 2.3 : 1 • RQD 85 (A)
🔒 Setup #3: 13.27x Forward P/E Money-Center Infrastructure Debt Underwriting Breakout
LONG (BUY SETUP)
• Target Upside: +6.2% (T1) to +10.5% (T2)
• Max Downside Stop: -4.5% Hard Floor (2.3 : 1 R/R)
Big-bank infrastructure lender breaking out with a -4.5% stop floor. Enter your email below for the entry zone and target.
Horizon: 5–12 Trading Days (Relative-Strength Financials Breakout)
⚡ See Setups #2 & #3 Right Now + Tomorrow's 3 Setups at 8:00 AM ET
Free impersonal market research. Educational levels only — past setups include losing stops and carry real risk of loss.
2. Guru Strategy Screeners, Formula Hub & Head-to-Head Battles
4. Editorial Investigations, FRED Macro & Interactive Tools
LIVE TAPE